Metabolic Syndrome: An Update for Pharmacy Professionals

Contact Hours: 3.0

ACPE UAN: 0384-9999-20-103-H01-T

The National Pharmacy Technician Association (NPTA) is accredited by the Accreditation Council for
Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Target Audience: Certified Pharmacy Technicians

This CPE activity has been designated as a knowledge-based program.

Author: Lorenza Jackson, RPhT, CPI, MBA

About the Author: Lorenza Jackson is a Certified Postsecondary Instructor with over two decades of pharmcay experience. She holds a bachelor's degree in Biological Sciences and a Master's in Business Administration with a specialization in Health Care Management.  She currently works at a health care company in clinical pharmacy operations.

DISCLAIMERS
Ms. Jackson has no actual or potential conflict of interest in relation to this program. 
This program received no commercial support and has been peer-reviewed to ensure non-commercialization.

Goals & Objectives:
At the completion of this activity, participants should be able to:

• List the criteria for the clinical diagnosis of metabolic syndrome

• List the risk factors for developing metabolic syndrome

• Recognize the etiologic factors that are correlated with metabolic syndrome

• List the diseases that are commonly associated with metabolic syndrome

• Counsel a patient on the non-pharmacological treatment for metabolic syndrome

• Recognize the pharmacological parameters for managing a patient on anti-obesity medications as indicated for metabolic syndrome

• Recognize the pharmacological parameters for managing a patient on lipid lowering medications as indicated for metabolic syndrome

• Explain the role of the renin angiotensin system inhibitors in patients with hypertension who have metabolic syndrome

• Recognize the clinical significance of how the different diabetic agents are beneficial in metabolic syndrome

• Recognize the pharmacological parameters for managing a patient on specific diabetic medications as indicated for metabolic syndrome

• Recognize why Cilostazol is beneficiall in metabolic syndrome

• Recognize the pharmacological parameters for managing a patient on Cilostazol as indicated for metabolic syndrome

• List the long-term consequences of metabolic syndrome

Release Date: 07/22/2020
Expiration Date: 07/22/2023